O Ministry of Health prepared a document contraindicating the use of chloroquine, azithromycin and ivermectin - known as the “Covid kit” - in the treat Covid-19. The official page of the folder had already removed, a week ago, old guidelines for the use of medicines.

Called “Brazilian Guidelines for Hospital Treatment of Patients with Covid-19”, the document, which was obtained by TV Globo and first published in G1, also mentions other drugs, such as hydroxychloroquine and remdesivir, defended by the president, Jair Bolsonaro.


In May of last year, the then Minister of Health, Eduardo Pazuello, had changed the protocols releasing the SUS to prescribe chloroquine for patients with mild symptoms of the disease. At the time, it was prescribed only for severe cases of the infection and the change occurred according to Bolsonaro's desire.

Ministry of Health issues document contraindicating the use of the 'Covid kit'. Image: Shutterstock
Ministry of Health issues document contraindicating the use of the 'Covid kit'. Image: Shutterstock

The change in protocol was even one of the reasons for friction between the president and the last two ministers of health: Luiz Henrique Mandetta and Nelson Teich.

Now, the report will proceed to the evaluation and public consultation by the National Commission for the Incorporation of Technologies in SUS (Conitec).

There are no data to prove the efficacy of the drugs that make up the “Covid kit”. The World Health Organization (WHO) has been warning since the second half of last year that the drugs have no proof of effectiveness and, in addition, they can cause side effects.

Read more:

Covid CPI

One of the issues investigated in Covid's Parliamentary Inquiry Commission (CPI) created by the Senate, is the indication of ineffective drugs to treat covid-19 patients.

Recently, in testimony, ex-minister Mandetta stated that the government proposed to the National Health Surveillance Agency (Anvisa) to change the label of chloroquine so that the drug was indicated for the treatment of the disease. President Anvisa, Antônio Barra Torres, confirmed the information.

Have you watched our new videos on UAF YouTube? Subscribe to our channel!